Inhibitors of Cyclin-dependent Kinases as Anti-tumor Agents

Explore the intricate world of cyclin-dependent kinases (CDKs) with the insightful book Inhibitors of Cyclin-dependent Kinases as Anti-tumor Agents by Taylor & Francis Inc. Published in 2006, this comprehensive hardback volume spans 448 pages, delving into the molecular and functional roles of CDKs in various disease processes.

This essential resource discusses the integration of cell cycle control pathways and highlights the promising opportunities for pharmacological modulation. Gain a deeper understanding of how these inhibitors can serve as potential anti-tumor agents, targeting specific pathways to combat cancer effectively.

Whether you are a student, researcher, or professional in the field, this book will enhance your knowledge of CDKs and their significance in cancer treatment. Don't miss the chance to add this valuable reference to your collection!